Telmisartan Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Jubilant Cadista., Aurobindo Pharma., Solco Healthcare, Sandoz International GmbH

Telmisartan Market

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.

The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.

Request for Sample of Telmisartan Market to know which pharma-biotech company is expected to be at the forefront in the coming years @

Some of the Prominent/Emerging Players in Telmisartan Market:

Mylan N.V., Hikma Pharmaceuticals PLC, Exelan Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., Jubilant Cadista., Aurobindo Pharma., Solco Healthcare, Sandoz International GmbH

Key Questions regarding Current Telmisartan Market Landscape

1. What are the current options for Telmisartan Market?
2. How many companies are developing for the Telmisartan Market?
3. What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and significant licensing activities that will impact the Telmisartan market?
4. Which are the dormant and discontinued products and the reasons for the same?
5. What is the unmet need for current Telmisartan Market?
6. What are the current novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing Telmisartan?
7. What are the critical designations that have been granted for Telmisartan Market?

The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Reasons to Buy:

1. The nature of Telmisartan business opportunities has grown in complexity with the industry evolving at a greater pace, making it increasingly difficult going without adequate information on markets and companies.
2. Gain a complete understanding of Global Telmisartan industry through the comprehensive analysis
3. Evaluate the pros and cons of investing/operating in country level Telmisartan markets through reliable forecast model results
4. Identify potential investment/contract/expansion opportunities
5. Drive your strategies in the right direction by understanding the impact of latest trends, market forecasts on your Telmisartan business
6. Beat your competition through information on their operations, strategies and new projects
7. Recent insights on the Telmisartan market will help users operating in the market to initiate transformational growth

Interested in Purchasing this Report? Click here @

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi
Phone : +1-646-491-9876
E-mail :

Related Articles

Back to top button